Stay updated with breaking news from Simon Beaudoin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Original-Research: Defence Therapeutics Inc. - von GBC AG Einstufung von GBC AG zu Defence Therapeutics Inc. Unternehmen: Defence Therapeutics Inc. ISIN: CA24463V1013 Anlass der Studie: Research
Original-Research: Defence Therapeutics Inc. - von GBC AGEinstufung von GBC AG zu Defence Therapeutics Inc.Unternehmen: Defence Therapeutics Inc.ISIN: CA24463V1013Anlass der Studie: Research CommentEmpfehlung: -Kursziel: -Letzte Ratingänderung: Analyst: Julien Desrosiers, Cosmin FilkerGBC Research Watchlist: Defence...